Skip to main content
From Data To Health

Our Mission: To Revolutionize Drug Development and Personalize Care

Our Story

BC Platforms is a global leader in building data networks for the life sciences industry and providing versatile technology platforms for ​research and precision medicine, accelerating the translation of innovations into clinical practice.

We convert complex biological information collected in the healthcare setting into actionable insights. With our innovative technology, we are creating a patient centric infinity loop between the life sciences and healthcare sectors. Data we generate, harmonize, and manage from diverse biobanks and healthcare institutions is made accessible for pharmaceutical and biotech companies to enhance their core strengths in research and development. In parallel, we enable stratification of patients towards targeted therapies, delivering on the promise of more personalized healthcare.​ The invaluable insights from real-world data, combined with our state-of-the-art technology platform, form an infinite loop where research accelerates discovery, discoveries enhance treatment, and treatment optimizes care.

Founded in 1997 from a MIT Whitehead project spinoff, we have a strong scientific heritage underpinned by over 25 years of working in close collaboration with a network of leading researchers, developers, and industry partners. We have global operations with our headquarters in Zurich, Switzerland, R&D in Espoo, Finland, and Singapore, as well as a presence in London, UK, Lund, Sweden, Paris and Toulouse, France and Boston, USA.

Follow us on LinkedIn.

Building the Foundation: BC Platform’s Journey from 1997 to Today and Beyond


Founded in Helsinki, Finland


BC Platforms’ first large-scale genome data discovery solution is released


Partnerships expand to offer solutions for biomarker discovery


BC Platforms released the next generation of our solution, seamlessly integrating genomic and clinical data geared for clinical genomics applications


Partnerships expand to advance Artificial Intelligence (AI) Solutions in healthcare


Comprehensive personalized medicine platform powered by BC|GENOME is released

New partnerships with Microsoft and Google Cloud, including healthcare integrators Tieto and Intersystems

Launch of Global Federated Data Partner Network


Partnership with IQVIA to extend data analytics in genomics


Recipients of the 2020 Microsoft Health Innovation Award for our precision medicine collaboration with Kaiser Permanente


New version of BC|RQUEST is released to revolutionize drug discovery and development

Acquisition of 4Pharma and Medexprim, paving the way for global leadership in Real-World Data


Our Collaborative Team

Meet the dedicated individuals who drive our vision and mission. Our team is comprised of passionate professionals, from our esteemed board and accomplished management team to our esteemed scientific advisory board. Together, they bring a wealth of experience, expertise, and leadership to our organization. Get to know the people who make our success possible

Diversity and Inclusion in the Workplace

Decorative Image

BC Platforms is committed to diversity and inclusion in the workplace. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, age, national origin, disability, gender identity or any other factor protected by applicable local regulations.

At BC Platforms our diverse and inclusive workplace expands opportunities for everyone. BC Platforms operates globally and benefits from a team of 23 nationalities and we aim to continue to increase diverse representation at all levels of the company.

Every client, partner and employee can and should bring their ideas and opinions to life. We realize that diverse perspectives and inclusive environments produce new ideas, innovation and drive our values also beyond our organization.

Our recruitment, career development and compensation are based on competence, performance and driving our values for impact. We treat everyone fairly no matter of their background, color, ethnicity, religion, gender or orientation our team members and stakeholders are representing.

We Are Proud Members of Many Industry Associations:

Where Innovation Meets Impact:
Join the BC | Team

Located around the world, our team of talented professionals are solving the most interesting genetic and clinical data challenges and we’re looking for ambitious, enthusiastic, and hardworking individuals to join us in revolutionizing drug development and patient care.

Stay Informed

Discover Our Innovations, Achievements and Updates

JPP Opening Ceremony image
15 April, 2024

BC Platforms and NTT Group Announce Official Opening Ceremony for Exclusive Collaboration and Launch of Japanese Precision Medicine Platform

BC Platforms Announces Executive Leadership Changes
29 February, 2024

BC Platforms Announces Executive Leadership Changes 

07 December, 2023

BC Platforms Acquires Medexprim, Paving the Way for Global Leadership in Real-World Data and Real-World Evidence Analytics

Learn More About BC Platforms

We are excited to be partnering with BC Platforms to bring personalized healthcare solutions into our clinical practice and research. We are looking forward to working with BC Platforms to set a new standard for predictive medicine complementing conventional treatment for our patients and clients across the globe.

Artirat Charukitpipat, Chief Executive Officer | Bumrungrad

We are excited to be collaborating with BC Platforms to securely share our data for the benefit of patients without compromising any privacy issues. We have been impressed by the platform and its ability to analyze, integrate and share data in a secure manner and in line with the European General Data Protection Regulation (GDPR) to support researchers in developing personalized medicines.

Dr. Christian Gülly COO Biobank Graz | Medical University of Graz, Austria

BC Platforms is quite unique in some aspects, because as a supplier it operates very much more as a collaborator. And from a platform perspective, very much of the work we are trying to achieve, both in medical research and utilizing new data science technology, and utilizing new techniques in medicine is very complicated and challenging, and so really having a partner, prepared to listen to us and taking critisism from us, is very enabling for us. So BC Platforms as a vendor is more of a partnership.

Prof. James Batchelor | University of Southampton, UK

The HELIOS study will thus provide a powerful resource for medical research across a wide range of disciplines for both the current and future generations of biomedical researchers. We’re delighted to have selected BC Platforms as a key delivery partner in this important healthcare project.

Professor John Chambers